CN Stock MarketDetailed Quotes

600422 KPC Pharmaceuticals, Inc.

  • 22.56
  • +0.14+0.62%
Market Closed May 21 15:00 CST
17.08BMarket Cap39.51P/E (TTM)

About KPC Pharmaceuticals, Inc. Company

The company was founded in March 1951 and listed on the Shanghai Stock Exchange in December 2000. The company has deep professional pharmaceutical experience, and is a national key high-tech enterprise and one of the top 100 enterprises in China's pharmaceutical industry. Relying on Yunnan's rich plant resources, Kunyao Group has successively developed more than 40 new natural medicine products with advanced levels at home and abroad, including the three major series of green artemisia, and specialty traditional Chinese medicine, and traditional Chinese medicine. At the same time, it has inherited the essence of Chinese medicine and has created a number of fine Chinese medicines represented by Shenlingjian spleen and stomach granules, liver relief granules, etc., gradually forming the four core business patterns of chronic disease management, healthy consumption, overseas international, and beautiful health. The company's industry is pharmaceutical manufacturing. Its business area covers the entire pharmaceutical industry chain, and its core business covers fields such as drug research and development, production and sales, pharmaceutical distribution, and the health industry. The company's core products include Kunyao Hemocalcitone series, artemisinyl ether series, Kunming Traditional Chinese Medicine Shenling Spleen and Stomach Granules, Hepatic Soothing Granules, Incense Stomach Calciferol softgels, sodium hyaluronate injections, etc. The company was selected as the “National Technological Innovation Demonstration Enterprise” assessed by the Ministry of Industry and Information Technology, the “2019 China Pharmaceutical Innovation Enterprise Top 100”, “Top 500 Chinese Enterprise Patents”, and “2022 Chinese Pharmacy Staff Recommendation Rate Brand”, ranked 13th in the “2022 Top 100 Proprietary Chinese Medicine Companies List” and ranked 12th in the “2022 Top 30 Chinese Medicine Listed Companies”. It won the “2023 Best Practice Case for Listed Company Directors” by the China Association of Listed Companies, Securities Daily Honors such as the “ESG Pioneer Practitioner” and the “Social Responsibility (S) Pioneer Enterprise Award” issued by the Financial Federation and the China Environmental Protection Federation.

Company Profile

Short Name-A昆药集团
Company NameKPC Pharmaceuticals, Inc.
Listing DateDec 6, 2000
Issue Price10.22
Shares Offered40.00M share(s)
FoundedDec 14, 1995
Listed ExchangeSH Stock Exchange
Legal Representativewei yan
General Managerwei yan
Secretarymengxun zhang
Accounting FirmKPMG Huazhen Certified Public Accountants (Special General Partnership)
Securities Representativeyu dong
Legal CounselBeijing Deheng (Kunming) Law Firm
Office AddressNo. 166, Medical Road, National High-tech Development Zone, Kunming, Yunnan
Zip Code650106
Registered AddressNo. 166, Medical Road, National High-tech Development Zone, Kunming, Yunnan
Business License530000000014415
BusinessProcurement, production and sale of raw materials and preparations of Chinese and Western medicine, chemical raw materials, intermediates, reagents, packaging materials, extracts, Chinese medicine tablets, agricultural by-products and Chinese herbal medicines (cultivation, acquisition and sale), industrial hemp cultivation, R&D, flower and leaf processing, domestic trade, material supply and marketing, goods and technology import and export business, technology development, consulting services, mechanical processing, pharmaceutical equipment manufacturing, installation and maintenance business, pharmaceutical engineering design, medical device management, foreign aid projects.

Company Executives

  • Name
  • Position
  • Salary
  • huawei qiu
  • Chairman,directors
  • --
  • hongshen li
  • Vice Chairman,directors,Member of the Strategy Committee
  • --
  • wei yan
  • Vice Chairman,directors,President
  • 678.30K
  • hui zhou
  • directors
  • --
  • zheng liang
  • directors
  • --
  • ting guo
  • directors
  • --
  • ke liu
  • Independent directors
  • 100.00K
  • jinguo xin
  • Independent directors
  • 100.00K
  • mengxun zhang
  • Board Secretary
  • 458.30K
  • yu dong
  • Securities affairs representative
  • --
  • jiang zhong
  • Chairman of the Supervisory Board,auditors
  • --
  • kang deng
  • auditors
  • --
  • jinfeng shao
  • auditors
  • --
  • junfeng liu
  • VP
  • 779.20K
  • li meng
  • VP
  • 608.30K
  • kai xi
  • VP
  • 396.70K
  • zhiqiang sun
  • Chief Financial Officer
  • 421.70K
  • wensen zhang
  • Employee supervisors
  • 300.00K
  • linxi li
  • Employee supervisors
  • 450.00K


Analyst Rating

No Data

Price Target

No Data

Heat List
Latest Price